Blood Purification
Original Paper
Heart Rate Variability in Peritoneal Dialysis Patients: What Is the Role of Residual Renal Function?Tang W.a · Li L.-X.b · Pei J.a · Wang T.aaDivision of Nephrology, Peking University Third Hospital, Beijing, and bGuangzhou Nansha District Hospital of Traditional Chinese Medicine, Guangzhou, PR China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: August 15, 2011
Accepted: March 18, 2012
Published online: August 24, 2012
Issue release date: September 2012
Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 4
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Abstract
Background: The relationship between heart rate variability (HRV) and residual renal function (RRF) has not been elucidated previously. Methods: In this cross-sectional study, HRV was evaluated in 71 peritoneal dialysis patients. Patients were divided into RRF decline group, RRF stable group and anuric group. Results: RRF was negatively correlated with SDNN (r = –0.284, p = 0.017), TP (r = –0.247, p = 0.039), and HF (r = –0.238, p = 0.047). Significant sympathetic nerve activation was found in the RRF decline group (significantly lower SDNN, SDSD, RMSSD, pNN50, LF, HF, TP and higher LF/HF ratio) as compared to the RRF stable and anuric groups. Besides, significantly parasympathetic activation was found in the anuric group (the lowest LF/HF ratio as compared to the other groups (both p < 0.05). Multivariate stepwise regression analysis showed that the status of RRF was an independent factor associated with HRV parameters. Conclusion: This study showed autonomic nervous function in peritoneal dialysis patients was associated with a different status of RRF.
© 2012 S. Karger AG, Basel
Related Articles:
References
-
Kleiger RE, Stein PK, Bigger JT Jr: Heart rate variability: measurement and clinical utility. Ann Noninvas Electrocardiol 2005;10:88–101.
External Resources
- Bernardi L, Keller F, Sanders M, Reddy PS, Griffith B, Meno F, Pinsky MR: Respiratory sinus arrhythmia in the denervated human heart. J Appl Physiol 1989;67:1447–1455.
-
Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, van Geijn HP: Heart rate variability. Ann Intern Med 1993;118:436–447.
External Resources
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043–1065.
- Ranpuria R, Hall M, Chan CT, Unruh M: Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant 2008;23:444–449.
- Reed MJ, Robertson CE, Addison PS: Heart rate variability measurements and the prediction of ventricular arrhythmias. QJM 2005;98:87–95.
- Routledge HC, Chowdhary S, Townend JN: Heart rate variability – a therapeutic target? J Clin Pharm Ther 2002;27:85–92.
-
Brotman DJ, Bash LD, Qayyum R, Crews D, Whitsel EA, Astor BC, Coresh J: Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 2010;21:1560–1570.
External Resources
-
Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP: The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 2010;33:521–528.
External Resources
- DiBona GF: Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 2005;289:R633–R641.
- DiBona GF: Neural control of the kidney: past, present, and future. Hypertension 2003;41:621–624.
- Di Leo R, Vita G, Messina C, Savica V: Autonomic function in elderly uremics studied by spectral analysis of heart rate. Kidney Int 2005;67:1521–1525.
-
Savica V, Musolino R, Di Leo R, Santoro D, Vita G, Bellinghieri G: Autonomic dysfunction in uremia. Am J Kidney Dis 2001;38:S118–S121.
External Resources
-
Jassal SV, Allen JA, Douglas JF, Stout RW: Autonomic function in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998;18:46–51.
External Resources
- Galetta F, Cupisti A, Franzoni F, Morelli E, Caprioli R, Rindi P, Barsotti G: Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis. Blood Purif 2001;19:395–400.
- Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N, Ojika K, Yagi K, Matsumoto H, Sohmiya S, Kimura G: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 2003;18:318–325.
- Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H: Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 2009;131:370–377.
- Kanbay M, Afsar B, Goldsmith D, Covic A: Sudden death in hemodialysis: an update. Blood Purif 2010;30:135–145.
- Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158–2162.
- Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307–1320.
- Szeto CC, Wong TY, Leung CB, Wang AY, Law MC, Lui SF, Li PK: Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients. Kidney Int 2000;58:400–407.
- Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, Chuang HF, Hung KY, Wu KD, Tsai TJ: Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009;24 2909–2914.
- van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:745–750.
- Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Keshaviah P: Cross-sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993;13:178–183.
- Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27–39.
- Rallison LR, Kushner RF, Penn D, Schoeller DA: Errors in estimating peritoneal fluid by bioelectrical impedance analysis and total body electrical conductivity. J Am Coll Nutr 1993;12:66–72.
- McCullough AJ, Mullen KD, Kalhan SC: Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991;14:1102–1111.
-
Chandra P, Sands RL, Gillespie BW, Levin NW, Kotanko P, Kiser M, Finkelstein F, Hinderliter A, Pop-Busui R, Rajagopalan S, Saran R: Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant 2011;27:700–709.
External Resources
-
Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B: Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 2000;248:21–26.
External Resources
- Dursun B, Demircioglu F, Varan HI, Basarici I, Kabukcu M, Ersoy F, Ersel F, Suleymanlar G: Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study. Ren Fail 2004;26:35–38.
- Joles JA, Koomans HA: Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004;43:699–706.
-
Ritz E, Rump LC: Control of sympathetic activity – new insights; new therapeutic targets? Nephrol Dial Transplant 2010;25:1048–1050.
External Resources
- Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH: Sympathetic nerve activity in end-stage renal disease. Circulation 2002;106:1974–1979.
-
Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW: Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009;20:933–939.
External Resources
- Vonend O, Rump LC, Ritz E: Sympathetic overactivity – the Cinderella of cardiovascular risk factors in dialysis patients. Semin Dial 2008;21:326–330.
- Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M: Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275–1281.
Article / Publication Details
Received: August 15, 2011
Accepted: March 18, 2012
Published online: August 24, 2012
Issue release date: September 2012
Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 4
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission